Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 91 of the Companies Act, 2013, Ajanta Pharma has informed that the Company shall close its Equity Share Transfer Books from Thursday, 28th June, 2018 to Thursday, 5th July, 2018 for the purpose of 39th Annual General Meeting to be held on Thursday, 5th July 2018. For dispatch of annual reports, the company shall be taking beneficiary position as on 25th May, 2018. As such, shareholders as on 25th May, 2018 will be sent annual reports. Cut-off date for the purpose of voting on resolutions to be passed at the 39th Annual General Meeting would be 28th June, 2018. As such, shareholders holding shares as on 28th June, 2018 will be entitled to vote on the resolutions to be passed at the Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: